Watson Pays $27M To Exit Drug Inflation MDL
Watson Pharmaceuticals Inc. on Tuesday agreed to pay $27 million to settle the remaining whistleblower claims against it in the Massachusetts multidistrict litigation accusing several pharmaceutical companies of reporting inflated drug...To view the full article, register now.
Already a subscriber? Click here to view full article